Around £3 million has been awarded to clinicians and scientists in Cambridge to support cancer research and find new treatments. Read more
The artificial pancreas for type 1 diabetes – which was developed in Cambridge and supported in trials by the NIHR Cambridge BRC and NIHR Cambridge CRF – could soon be approved for use Read more
Research supported by NIHR Cambridge BRC has led to a new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, giving highly accurate results in under Read more
Researchers in this theme will be looking at finding better ways to predict and prevent stillbirth and infant mortality. Read more
This theme will investigate heart and lung diseases and how using artificial intelligence (AI) could identify patterns in data to improve diagnosis. Read more
Researchers will explore the use of population data to improve early detection health conditions to change outcomes. Read more
Developed in line with the Life Sciences Vision 2021, this theme aims to expedite patient access to new treatments & technologies.Read more
Working with our partners, including patients, this theme aims to drive adoption of genomics into everyday healthcare.Read more
This theme will explore ways to develop personalised treatments for patients with immune disorders and improve outcomes of organ transplants. Read more
Cambridge has a strong track record in microbiology and infectious diseases research, from basic science to clinical studies. Read more
Researchers will study the links between physical and mental health conditions, as well as improve therapies and treatments. Read more
This theme aims to develop treatments for all dementias, as well as creating new diagnostic tools to identify the disease earlier.Read more
Neurological disorders affect 1 in 6 in the UK and are complex and highly variable, with limited treatment opportunities. Read more
Our research aims are to improve the lives and health of people with obesity, diabetes and related metabolic and endocrine diseases. Read more